Source: Eur Respir J 2007; 29: 995-1002
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
De Wever W., Vankan Y., Stroobants S., Verschakelen J.. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer. Eur Respir J 2007; 29: 995-1002

Member's Comments

No comment yet.

Related content which might interest you: Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009 Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer Year: 2008 The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245 Year: 2004 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) Source: Eur Respir J 2004; 24: Suppl. 48, 457s Year: 2004 Assessing nodules detected in lung cancer screening: the value of positron emission tomography Source: Eur Respir J 2015; 45: 314-316 Year: 2015 Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery Year: 2008 Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Imaging in lung cancer: positron emission tomography scan Source: Eur Respir J 2002; 19: 49S-60S Year: 2002 Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Source: Eur Respir J 2001; 17: 802-820 Year: 2001 False- positive and false-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in non-small-cell lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 The role of FDG positron emission tomography in mediastinal lymph node evaluation for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 125s Year: 2006 Value of positron emission tomography parameters for the prognosis of small-cell lung carcinoma Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Computed tomography in staging for lung cancer Source: Eur Respir J 2002; 19: 40S-48S Year: 2002 (18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013